Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Mov Disord. 2015 Sep 21;31(2):225–234. doi: 10.1002/mds.26428

Figure 1. Windows for therapeutic intervention in synucleinopathies.

Figure 1

Hypothetical disease progression in stages postulated for PD and other synucleinopathies, including α-syn deposition, death of selected neuronal populations, neuroinflammation and cognitive and motor deficits. Suggested treatments that could be suitable for each therapeutic window of opportunity are depicted below.